Rinucumab

Rinucumab Uses, Dosage, Side Effects, Food Interaction and all others data.

Rinucumab is under investigation in clinical trial NCT02418754 (Study of Intravitreal REGN2176-3 in Participants With Neovascular ("Wet") Age-related Macular Degeneration (AMD)).

Trade Name Rinucumab
Generic Rinucumab
Rinucumab Other Names Immunoglobulin g4, anti-(human platelet-derived growth factor receptor~) (human monoclonal regn2176 heavy chain), disulfide with human monoclonal regn2176 k-chain, dimer, Rinucumab
Type
Groups Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated: September 19, 2023 at 7:00 am
Rinucumab
Rinucumab

Innovators Monograph

You find simplified version here Rinucumab

*** Taking medicines without doctor's advice can cause long-term problems.
Share